Casting Versus Percutaneus Pinning Treatment of Pediatric Overriding Distal Forearm Fractures

June 29, 2020 updated by: Topi Laaksonen, Töölö Hospital

Casting in Finger-trap Traction Without Reduction Versus Closed Reduction and Percutaneous Pin Fixation of Dorsally Displaced, Overriding Distal Metaphyseal Radius Fractures in Under Eleven Years Old Children

This is a randomized controlled trial comparing casting in finger-trap traction without reduction versus closed reduction and percutaneous pin fixation of dorsally displaced, overriding distal metaphyseal radius fractures in under eleven years old children.

Study Overview

Detailed Description

Overriding pediatric distal radius fractures have been managed with anatomical reduction performed under anesthesia with or without percutaneous pinning. This research protocol was developed due to good results reported on leaving the fractures in an overriding position.

In this randomized controlled trial, we will compare objective outcomes between casting in finger-trap traction without reduction versus closed reduction and percutaneous pin fixation of dorsally displaced, overriding distal metaphyseal radius fractures in children.

Inclusion criteria are patients younger than 11 years old (Tanner 0) with completely overriding distal radius fractures. At the emergency department patients are randomized into two groups: finger trap traction and cast immobilization (experimental group) and anatomic reduction and percutaneous pin fixation (control group).

The current controversy is whether cast immobilization alone is an adequate stabilization or whether percutaneous pin fixation is more appropriate for displaced, complete, distal forearm (overriding) metaphyseal fractures. The objectives of this trial are to compare the outcomes between conservative treatment with finger trap method for completely displaced distal radius fractures and surgical treatment with percutaneous pinning. Our null hypothesis is that there are no radiological or clinically relevant differences in outcome measures between the two treatment groups. We consider non-inferiority proven if there is no clinically significant difference at 6 months between the two treatments groups in the primary outcome: ratio (%) of forearm rotation and wrist extension-flexion range of motion (ROM) compared to the non-affected side at 6 months (non-inferiority margin 10%).

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Helsinki, Finland
        • Recruiting
        • New Children's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 10 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Child with open epiphysis with closed overriding metaphyseal distal radial fracture with or without an associated fracture of the ulna
  • Normal communication development (languages Finnish, Swedish, English)

Exclusion Criteria:

  • Bilateral forearm injuries
  • Gustillo-Anderson grade II or III open fracture
  • Galeazzi fracture-dislocation
  • Polytrauma
  • Neurovascular injury of the ipsilateral upper extremity
  • History of a displaced forearm fracture
  • Underlying disease affecting fracture healing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Cast immobilization

In the casting group, padded synthetic dorsal above elbow and volar below elbow splints are applied in ED without local or general anesthesia. Dorsal displacement and shortening of the radius are not corrected, but the forearm is attempted to be manipulated straight during application of the splints. The casted forearm is then supported by a collar and cuff sling. Splints are removed in an outpatient clinic at 4 weeks.

Cast immobilization is discontinued after 4 weeks and when the fracture site is nontender. If palpated tenderness is still present, the patient is given a dorsal forearm splint which can be removed (maximum of 2 weeks usage).

Cast immobilisation is done using finger trap traction. The fractured forearm is splinted above elbow with dorsal cast without attempted reduction.
ACTIVE_COMPARATOR: Percutaneus pinning
In the surgery group, a padded dorsal above elbow splint is applied in ED. Reduction and percutaneous pinning are performed under anesthesia in operating room by an experienced attending pediatric orthopedic surgeon within 7 days from the injury. Pin fixation is performed with two 1.6 mm pins. Padded dorsal above elbow and volar below elbow splints are applied. Splints and pins are removed at the outpatient clinic at 4 weeks after surgery.
Reduction under fluoroscopic guidance and fixation using two crossing 1.6mm K-wires.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wrist ROM
Time Frame: 6 months
The ratio (injured side/non-injured side) in total active range of motion of the wrist in the flexion-extension plane.
6 months
Forearm ROM
Time Frame: 6 months
The ratio (injured side/non-injured side) in the total active forearm rotation.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-reported pain
Time Frame: 1 and 4 weeks, 3 and 6 months, 1 year
Pain at rest and in activities is assessed on PedsQL questionnaire. Range 0 to 100 mm, 0 best.
1 and 4 weeks, 3 and 6 months, 1 year
Patient-reported outcome (PROM)
Time Frame: 4 weeks, 3 and 6 months, 1 year
Quick-DASH, range 0 to 100, 0 best
4 weeks, 3 and 6 months, 1 year
Radiographic outcomes
Time Frame: 1 and 4 weeks, 3 and 6 months, 1 year
Sagittal and coronal plain radiographs
1 and 4 weeks, 3 and 6 months, 1 year
Grip strength
Time Frame: 3 and 6 months, 1 year
Objective grip strength measurement using dynamometer
3 and 6 months, 1 year
Forearms length
Time Frame: 3 and 6 months, 1 year
Length of forearms and hands
3 and 6 months, 1 year
Wrist ROM
Time Frame: 3 months, 1 year
The ratio (injured side/non-injured side) in total active range of motion of the wrist in the flexion-extension plane.
3 months, 1 year
Forearm ROM
Time Frame: 3 months, 1 year
The ratio (injured side/non-injured side) in the total active forearm rotation.
3 months, 1 year
Overall satisfaction
Time Frame: 6 months
The patient's parent(s) or guardian(s) are queried about their satisfaction with the treatment. The satisfaction of the function of the fractured upper extremity and its effect on the patient's daily living and satisfaction to the cosmetic outcome are recorded on a 5-step Likert scale.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 29, 2020

Primary Completion (ANTICIPATED)

December 31, 2023

Study Completion (ANTICIPATED)

December 31, 2025

Study Registration Dates

First Submitted

March 24, 2020

First Submitted That Met QC Criteria

March 25, 2020

First Posted (ACTUAL)

March 26, 2020

Study Record Updates

Last Update Posted (ACTUAL)

July 1, 2020

Last Update Submitted That Met QC Criteria

June 29, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Overriding Distal Metaphyseal Radius Fractures

Clinical Trials on Cast immobilization

3
Subscribe